Awards and Grants

Jakob Olfe, MD, (University Heart and Vascular Center Hamburg) is, together with other scientists, the winner of the Kurt and Erika Palm Foundation Science Prize, which is awarded by the German Heart Foundation and the German Society for Prevention and Rehabilitation of Cardiovascular Diseases (DGPR).

For his achievements as a clinically active cardiologist and his scientific success in deciphering the genetic causes of heart attacks, Heribert Schunkert was awarded the Order of Merit by the Bavarian Minister-President on 5 July. Schunkert is Principal Investigator at the DZHK partner site in Munich.

Prof. Dr. rer. nat. Sofia-Iris Bibli (Goethe University Frankfurt) receives the Hector Research Career Development Award. Her research focuses on metabolic surveillance mechanisms that control vascular regeneration.

For his achievements as a clinically practicing cardiologist and his scientific successes in decoding the genetic causes of heart attacks, Prof. Dr. Heribert Schunkert (German Heart Centre Munich) was awarded the Order of Merit by the Bavarian Minister President on July 5, 2023.

The European Molecular Biology Organization EMBO has elected Michael Potente, Principal Investigator at the DZHK partner site in Berlin, as a new member. He is joining a community of more than 2,000 leading life scientists in Europe and beyond. Potente is Professor for Translational Vascular Biomedicine and head of the Angiogenesis & Metabolism Laboratory at the Max Delbrück Center and Berlin Institute of Health at Charité (BIH).

The European scientific organization EMBO has elected Prof. Dr. Michael Potente (Max Delbrück Center and Berlin Institute of Health at Charité) as a new member. This makes him one of more than 2,000 leading bioscientists in Europe.

PD Dr. med Leo Nicolai (Ludwig-Maximilians-Universität Munich) was able to acquire a junior research group in the field of cardiovascular diseases by the Corona Foundation. The funding comprises around €1 million over five years and aims to reveal new therapeutic, diagnostic and prognostic approaches in thrombosis.

Dr. Redouane Aherrahrou and his junior research group at the Institute for Cardiogenetics at the University of Lübeck receive funding from the Corona Foundation for research into the genetic causes of coronary artery calcification (CAC) and its sex differences.

Prof. Dr. Lutz Ackermann (University of Göttingen) receives a research award worth more than €1 million in the "Project of the Century" competition organized by the Werner Siemens Foundation (WSS).

Prof. Dr. Michael Zeisberg, Prof. Dr. Lutz Ackermann (both University Medical Center Göttingen, UMG) and their teamcan look forward to €1.5 million in start-up funding from the Institute for Biomedical Translation (IBT) from the state of Lower Saxony. Their project RevOFib (Reversal of Fibrosis) contains a portfolio of anti-fibrotic approaches in multiple stages of development for the treatment of patients with chronic kidney disease.